Close
The page header's logo
Help
Login
Staff Login
Register
FR
0
Selected 
Invert selection
Deselect all
Deselect all
 Add to Cart
 Click here to refresh results
 Click here to refresh results
Go to Login page
 Hide details
doctype icon
Conceptually similar
US to share AstraZeneca shots with world
play button
CP122305760 | US to share AstraZeneca shots with world 
AstraZeneca vaccine authorized in Canada
play button
CP118971421 | AstraZeneca vaccine authorized in Canada 
South Africa suspends AstraZeneca vaccine plan
play button
CP117407821 | South Africa suspends AstraZeneca vaccine plan 
AstraZeneca vaccine's benefits vastly outweigh risks: Sharma
play button
CP120476771 | AstraZeneca vaccine's benefits vastly outweigh risks: Sharma 
AstraZeneca blood clot risk remains low: Tam
play button
CP122017117 | AstraZeneca blood clot risk remains low: Tam 
Newly eligible people receive Oxford-AstraZeneca vaccine
play button
CP121946460 | Newly eligible people receive Oxford-AstraZeneca vaccine 
Ontario to get more than 250,000 AstraZeneca doses
play button
CP123251321 | Ontario to get more than 250,000 AstraZeneca doses 
N.S. pauses use of AstraZeneca vaccine
play button
CP123262421 | N.S. pauses use of AstraZeneca vaccine 
Second-dose choice likely for AstraZeneca recipients: Tam
play button
CP123597771 | Second-dose choice likely for AstraZeneca recipients: Tam 
Manitoba approves different second dose after AstraZeneca COVID-19 vaccine
play button
CP124342421 | Manitoba approves different second dose after AstraZeneca COVID-19 vaccine 
Action button

US: AstraZeneca results may include outdated info

American federal health officials say results from a U.S. trial of AstraZeneca's COVID-19 vaccine may have included "outdated information" and that could mean the company provided an incomplete view of efficacy data. (March 23) 
Actions
 Add to collection
 Add to cart
Information
Source name: 
The Associated Press
Unique identifier: CP120471614 
Legacy Identifier: e3ac1850f6bc4ee7983c3f41dc9c2ee9 
Type: Video 
Duration: 1m37s 
Dimensions: 1920px × 1080px     118.91 MB 
Usage rights: Digital platform use only. Broadcast rights and editing of content prohibited. 
Create Date: 3/23/2021 2:00:17 PM 
Display aspect ratio: 16:9